glp-1 agonist dementia Glucagon-like peptide-1 medicines in neurological and psychiatric disorders: Cell Reports Medicine GLP-1R agonists protect against Alzheimer's

The extra glutathione we have delivered into the intestinal cells then diffuses out into the bloodstream

Exenatide in acute ischemic stroke

Risks, Side Effects, and Who Should Be Cautious Safety plays a crucial role in comparing NAD+ and NMN supplements

The Food and Drug Administration (FDA) closed 124 cases of illegal GLP-1 drug sales from 2024 to 2026, resulting in fines of nearly NT$3.6 million (over US$112,000)

Why proper storage matters after reconstitution Lyophilized peptides are forgiving

Fueled by rising demand for weight loss drugs, FDA approvals for Wegovy and Zepbound, and mounting evidence of long-term health benefits, obesity prescriptions are outpacing those for diabetes in many countries